Ribavirin and interferon alpha-2b combination treatment of chronic hepatitis C is effective in patients with clotting disorders

被引：0
|
作者：
Fried, R
Meili, E
Peter, K
Hartmann, S
Tsakiris, D
Egger, H
Marbet, G
机构：
[1] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
[2] Univ Basel Hosp, CH-4031 Basel, Switzerland
[3] Kantonsspital Chur, Chur, Switzerland
来源：
GASTROENTEROLOGY | 2001年 / 120卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1962
引用
收藏
页码：A382 / A383
页数：2
相关论文
共 50 条
  • [1] Ribavirin in combination with alpha-2b interferon for the treatment of chronic hepatitis C
    Hillon, P
    [J]. PRESSE MEDICALE, 2001, 30 (07): : 335 - 336
  • [2] Triple combination of interferon alpha-2b, ribavirin, and amantadine for treatment of chronic hepatitis C
    Younossi, ZM
    Mullen, KD
    Hodnick, S
    Barnes, DS
    Carey, WD
    McCullough, AC
    Easley, K
    Gramlich, T
    Liebermann, BY
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 36 (05) : 427 - 430
  • [3] Combination therapy with interferon alpha-2b and ribavirin in naive patients with chronic hepatitis C
    Juszczyk, J
    Bolewska, B
    Cianciara, J
    Jablonska, J
    Zaborowski, P
    Niedzialek, D
    Gladysz, A
    Piszko, P
    [J]. JOURNAL OF HEPATOLOGY, 2000, 32 : 199 - 199
  • [4] Combination treatment of interferon alpha-2b and ribavirin in comparison to interferon monotherapy in treatment of chronic hepatitis C genotype 4 patients
    El-Zayadi, A
    Selim, O
    Haddad, S
    Simmonds, P
    Hamdy, H
    Badran, HM
    Shawky, S
    [J]. ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (06): : 472 - 475
  • [5] A pragmatic and cost-effective strategy of a combination therapy of interferon alpha-2b and ribavirin for the treatment of chronic hepatitis C
    Sagmeister, M
    Wong, JB
    Mullhaupt, B
    Renner, EL
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2001, 13 (05) : 483 - 488
  • [6] Peg interferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for treatment of chronic hepatitis C in treatment-naive patients in Egypt
    Elwaki, M. R.
    Montasser, M. F.
    Mansour, M. A.
    Salman, T. A.
    El-Batanony, M. H.
    Helail, E. H.
    Shehata, K. O.
    Attallah, K. M.
    Madwar, M. A.
    [J]. LIVER INTERNATIONAL, 2006, 26 : 84 - 84
  • [7] Interferon alpha-2b and ribavirin for patients with chronic hepatitis C and normal ALT
    Mukherjee, S
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (03): : 727 - 727
  • [8] Interferon alpha-2b and ribavirin for patients with chronic hepatitis C and normal ALT
    Jacobson, IM
    Ahmed, F
    Russo, MW
    Lebovics, E
    Dieterich, DI
    Esposito, SP
    Bach, N
    Klion, F
    Tobias, H
    Antignano, L
    Brown, RS
    Gabbaizadeh, D
    Geders, J
    Levendoglu, H
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (09): : 1700 - 1705
  • [9] Early prediction of nonresponders to treatment with interferon alpha-2b and ribavirin in patients with chronic hepatitis C
    Liu, LWC
    Tomlinson, G
    Mazzulli, T
    Murray, A
    Heathcote, J
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY, 2003, 17 (08): : 483 - 487
  • [10] Peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for treatment of chronic hepatitis C in treatment-naive Egyptian patients
    El-Wakil, R. M.
    Montasser, M. F.
    Mansour, M. A.
    Salman, T. A.
    EL-Batanony, M. H.
    Helail, E. H.
    Shehata, K. O.
    Attallah, K. M.
    Madwar, M. A.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S142 - S143
12345